329 related articles for article (PubMed ID: 1324534)
1. Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery.
Koppenhagen K; Adolf J; Matthes M; Tröster E; Roder JD; Hass S; Fritsche HM; Wolf H
Thromb Haemost; 1992 Jun; 67(6):627-30. PubMed ID: 1324534
[TBL] [Abstract][Full Text] [Related]
2. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
3. [Thromboembolism prophylaxis with low molecular weight heparin in abdominal surgery].
Adolf J; Knee H; Roder JD; van de Flierdt E; Siewert JR
Dtsch Med Wochenschr; 1989 Jan; 114(2):48-53. PubMed ID: 2535983
[TBL] [Abstract][Full Text] [Related]
4. Prevention of postoperative deep vein thrombosis in cancer patients. A randomized trial with low molecular weight heparin (CY 216).
Marassi A; Balzano G; Mari G; D'Angelo SV; Della Valle P; Di Carlo V; D'Angelo A
Int Surg; 1993; 78(2):166-70. PubMed ID: 8394842
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis of thromboembolic disease with RO-11 (ROVI), during abdominal surgery. EMRO1 (Grupo Fstudio Multicintrico RO-11).
Moreno Gonzalez E; Fontcuberta J; de la Llama F
Hepatogastroenterology; 1996; 43(9):744-7. PubMed ID: 8799424
[TBL] [Abstract][Full Text] [Related]
6. Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial.
Haas S; Flosbach CW
Semin Thromb Hemost; 1993; 19 Suppl 1():164-73. PubMed ID: 8395721
[TBL] [Abstract][Full Text] [Related]
7. An international multicentre study: Clivarin in the prevention of venous thromboembolism in patients undergoing general surgery. Report of the International Clivarin Assessment Group.
Boneu B
Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S21-2. PubMed ID: 8180325
[TBL] [Abstract][Full Text] [Related]
8. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J
Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863
[TBL] [Abstract][Full Text] [Related]
9. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
10. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
11. Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin.
Haas S; Wolf H; Kakkar AK; Fareed J; Encke A
Thromb Haemost; 2005 Oct; 94(4):814-9. PubMed ID: 16270636
[TBL] [Abstract][Full Text] [Related]
12. A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the prevention of deep vein thrombosis in general surgery. A French multicenter trial.
Caen JP
Thromb Haemost; 1988 Apr; 59(2):216-20. PubMed ID: 2838923
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
[TBL] [Abstract][Full Text] [Related]
14. Prevention of postoperative deep vein thrombosis by one daily injection of low molecular weight heparin and dihydroergotamine.
Baumgartner A; Jacot N; Moser G; Krähenbühl B
Vasa; 1989; 18(2):152-6. PubMed ID: 2545054
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial.
Lopaciuk S; Meissner AJ; Filipecki S; Zawilska K; Sowier J; Ciesielski L; Bielawiec M; Glowinski S; Czestochowska E
Thromb Haemost; 1992 Jul; 68(1):14-8. PubMed ID: 1325076
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of thrombosis in gynecology: double-blind comparison of low molecular weight heparin and unfractionated heparin].
Heilmann L; Kruck M; Schindler AE
Geburtshilfe Frauenheilkd; 1989 Sep; 49(9):803-7. PubMed ID: 2553528
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
Bergqvist D
Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
[TBL] [Abstract][Full Text] [Related]
18. [Biological criteria for the evaluation of prophylactic treatment with a low molecular weight heparin (Kabi 2165)].
Le Querrec A; Derlon A; Deshayes JP; Lefrançois C; Sillard B; Delassus P; Viel JF; Kher A; Thomas M
J Mal Vasc; 1987; 12 Suppl B():99-101. PubMed ID: 2834502
[TBL] [Abstract][Full Text] [Related]
19. A low molecular weight heparin (KABI 2165) for prophylaxis of postoperative deep venous thrombosis.
Onarheim H; Lund T; Heimdal A; Arnesjø B
Acta Chir Scand; 1986 Oct; 152():593-6. PubMed ID: 3544625
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic defense during the postoperative period. Clinical documentation of low molecular weight heparin.
Welzel D; Wolf H; Koppenhagen K
Arzneimittelforschung; 1988 Jan; 38(1):120-3. PubMed ID: 2835055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
